

The Role of Imaging in Metastatic Colorectal Cancer Management
A review of the management of metastatic colorectal cancer and the role of imaging in treatment strategy.
Course ID: Q00419 Category: Radiology Trends for Technologists Modalities: CT, MRI, Nuclear Medicine, PET, Radiation Therapy2.5 |
Satisfaction Guarantee |
$29.00
- Targeted CE
- Outline
- Objectives
Targeted CE per ARRT’s Discipline, Category, and Subcategory classification:
[Note: Discipline-specific Targeted CE credits may be less than the total Category A credits approved for this course.]
Computed Tomography: 1.00
Procedures: 1.00
Abdomen and Pelvis: 1.00
Magnetic Resonance Imaging: 1.25
Patient Care: 0.25
Patient Interactions and Management: 0.25
Procedures: 1.00
Body: 1.00
Nuclear Medicine Technology: 1.00
Procedures: 1.00
Endocrine and Oncology Procedures: 1.00
Outline
- Introduction
- Imaging of Metastases in CRC
- Ultrasonography
- Multidetector CT
- MR Imaging
- PET/CT
- Management of mCRC
- Surgery in mCRC
- Role of Imaging in Surgical Planning for mCRC
- Liver-directed Therapies in mCRC
- Role of Imaging in Liver-directed Therapies for mCRC
- Systemic Chemotherapy in mCRC
- Chemotherapeutic Regimens
- Novel MTTs
- Role of Imaging in Systemic Chemotherapy
- Complications and Toxicities Associated with Treatment of mCRC
- Complications Associated with Liver-directed Therapies
- Conclusion
Objectives
Upon completion of this course, students will:
- list the compounds in the FOLFOX and FOLFIRI chemotherapeutic regimens
- identify the most common site of CRC metastasis
- understand the barriers to performing contrast-enhanced US for the assessment of CRC liver metastases
- describe the sensitivity of intraoperative US in the evaluation of colorectal cancer
- identify the most commonly used imaging modality in the workup of patients with metastatic colorectal cancer
- understand the timing of the phases of enhancement following administration of intravenous CT contrast material
- describe the appearance of hepatic metastases on T1- and T2-weighted MR imaging
- list the conditions that may produce false-negative PET/CT results during imaging of mCRC
- identify the only definitive treatment for metastatic colorectal cancer
- understand the goal of conversion chemotherapy
- list the major determinants of liver metastasis resectability
- describe the liver-directed therapy capable of achieving a selective high-dose delivery of chemotherapeutic drugs
- recognize the most widely used local ablative procedure for colorectal cancer
- list the imaging modalities used to guide liver-directed therapies
- list the CRC MTTs that bind to vascular endothelial growth factor (VEGF) receptors
- list the mCRC treatments that are associated with cholecystitis
- identify the most widely used imaging modality in the assessment of mCRC treatment response
- describe the imaging findings associated with a good or optimal morphologic response to treatment in liver metastases
- list the imaging modalities that are recommended for assessment of treatment response
- describe the major complications associated with percutaneous ablation